Your browser doesn't support javascript.
loading
Clinical impact of the polypill for cardiovascular prevention in Latin America: a consensus statement of the Inter-American Society of Cardiology
Liprandi, Álvaro Sosa; Liprandi, Maria Inés Sosa; Alexánderson, Erick; Avezum, Álvaro; Lanas, Fernando; Lópes-Jaramillo, José Patricio; Ponte-Negretti, Carlos I; Wyss, Fernando; Juanatey, José Ramón González; Perel, Pablo; Negretti, Carlos I Ponte N; Martínez, Felipe.
Afiliación
  • Liprandi, Álvaro Sosa; Department of Cardiovascular, Sanatorio Güemes. Buenos Aires. AR
  • Liprandi, Maria Inés Sosa; Department of Cardiovascular, Sanatorio Güemes. Buenos Aires. AR
  • Alexánderson, Erick; Universidad Nacional Autónoma de México. Instituto Nacional de Cardiología Ignacio Chávez. Cidade do México. MX
  • Avezum, Álvaro; Instituto Dante Pazzanese de Cardiología. São Paulo. BR
  • Lanas, Fernando; Universidad de la Frontera Temuco. Temuco. CL
  • Lópes-Jaramillo, José Patricio; Universidad Tecnológica Equinoccial Quito. Eugenio Espejo Faculty of Health Sciences Ecuador. Quito. EC
  • Ponte-Negretti, Carlos I; Hospital Domingo Luciani. Caracas. VE
  • Wyss, Fernando; Servicios y Tecnología Cardiovascular de Guatemala S A. Guatemala. GT
  • Juanatey, José Ramón González; Hospital Universitario de Santiago de Compostela. Santiago de Compostela. ES
  • Perel, Pablo; London School of Hygiene and Tropical Medicine. Londres. GB
  • Negretti, Carlos I Ponte N; Hospital Domingo Lucian. Caracas. VE
  • Martínez, Felipe; Instituto Médico Damic. Córdova. AR
Glob Heart ; 14(1): 03-16, Mar. 2019. gráfico, tabela
Article en En | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1024845
Biblioteca responsable: BR79.1
ABSTRACT
The burden of cardiovascular diseases (CVD) is increasing, particularly in low-middle-income countries such as most of Latin America. This region presents specific socioeconomic characteristics, generating a high incidence of CVD despite efforts to control the problem. A consensus statement has been developed by Inter-American Society of Cardiology with the aim of answering some important questions related to CVD in this region and the role of the polypill in cardiovascular (CV) prevention as an intervention to address these issues. A multidisciplinary team composed of Latin American experts in the prevention of CVD was convened by the Inter-American Society of Cardiology and participated in the process and the formulation of statements. To characterize the prevailing situation in Latin American countries, we describe the most significant CV risk factors in the region. The barriers that impair the use of CV essential medications are also reviewed. The role of therapeutic adherence in CV prevention and how the polypill emerges as an effective strategy for optimizing adherence, accessibility, and affordability in the treatment of CVDs are discussed in detail. Clinical scenarios in which the polypill could represent an effective intervention in primary and secondary CV prevention are described. This initiative is expected to help professionals involved in the management of CVD and public health policymakers develop optimal strategies for the management of CVDs. (AU)
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
Buscar en Google

Texto completo: 1 Colección: 06-national / BR Base de datos: SES-SP / SESSP-IDPCPROD Asunto principal: Enfermedades Cardiovasculares Tipo de estudio: Risk_factors_studies Idioma: En Revista: Glob Heart Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
Buscar en Google

Texto completo: 1 Colección: 06-national / BR Base de datos: SES-SP / SESSP-IDPCPROD Asunto principal: Enfermedades Cardiovasculares Tipo de estudio: Risk_factors_studies Idioma: En Revista: Glob Heart Año: 2019 Tipo del documento: Article